A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics (PK) and to assess safety and
tolerability of a single dose of ASP3291 in subjects with ulcerative colitis.